Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities

Alieh Farshbaf1,2, Nooshin Mohtasham3, Reza Zare3

  • 1Dental Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Insights

MicroRNAs (miRs) play a dual role in COVID-19, with viral miRs targeting human genes and host miRs restricting viral replication. Understanding these miRs offers therapeutic opportunities for SARS-CoV-2 infection and related cancers.

Area of Science:

  • Molecular Biology
  • Virology
  • Genomics

Background:

  • COVID-19, caused by SARS-CoV-2, presents a significant global health challenge due to high pathogenicity and lack of specific treatments.
  • MicroRNAs (miRs) are small non-coding RNAs that regulate gene expression and are implicated in various biological processes, including immune response and inflammation.
  • SARS-CoV-2 infection involves complex interactions between viral and host miRs, affecting critical cellular functions and potentially contributing to disease severity.

Purpose of the Study:

  • To review the challenges and opportunities of using miRs as a therapeutic approach for SARS-CoV-2 infection.
  • To explore the role of miRs in saliva droplets during SARS-CoV-2 infection and their association with related cancers.
  • To highlight the potential of salivaomics in evaluating viral biomarkers like miRs for diagnostic and therapeutic purposes.

Main Methods:

  • Literature review of studies investigating the role of miRs in SARS-CoV-2 infection.
  • Analysis of miR-host interactions and their impact on viral pathogenesis.
  • Examination of therapeutic strategies involving miRs, such as mimic miRs and antagomirs.
  • Overview of salivaomics applications in detecting viral components and biomarkers.

Main Results:

  • SARS-CoV-2 encoded-miRs can modulate human gene expression involved in immune response, inflammation, and apoptosis.
  • Host miRs play a crucial role in controlling viral gene expression and limiting infection.
  • Dysregulation of miRs can lead to adverse outcomes, including impaired immune responses and potential oncogenesis.
  • Mimic miRs and antagomirs have shown promise in preclinical and clinical trials for mitigating the effects of viral miRs.

Conclusions:

  • MicroRNAs represent a promising avenue for therapeutic interventions against SARS-CoV-2 infection.
  • Further research into the precise roles of individual miRs is essential for developing targeted therapies.
  • Salivaomics offers a non-invasive approach for detecting SARS-CoV-2 and related biomarkers, potentially aiding in early diagnosis and management of infection and associated cancers.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
676
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.3K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.7K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.8K